机译:初级人视网膜上皮细胞MDM2 T309G突变的引入增强了实验增殖性玻璃体病变
Harvard Med Sch Schepens Eye Res Inst Massachusetts Eye &
Ear Boston MA USA;
Harvard Med Sch Schepens Eye Res Inst Massachusetts Eye &
Ear Boston MA USA;
Harvard Med Sch Schepens Eye Res Inst Massachusetts Eye &
Ear Boston MA USA;
Harvard Med Sch Schepens Eye Res Inst Massachusetts Eye &
Ear Boston MA USA;
Harvard Med Sch Schepens Eye Res Inst Massachusetts Eye &
Ear Boston MA USA;
Harvard Med Sch Schepens Eye Res Inst Massachusetts Eye &
Ear Boston MA USA;
Harvard Med Sch Massachusetts Eye &
Ear Dept Ophthalmol Boston MA USA;
Univ British Columbia Dept Ophthalmol &
Visual Sci Vancouver BC Canada;
Dalhousie Univ Halifax NS Canada;
Univ British Columbia Dept Ophthalmol &
Visual Sci Vancouver BC Canada;
Harvard Med Sch Massachusetts Eye &
Ear Dept Ophthalmol Boston MA USA;
Harvard Med Sch Schepens Eye Res Inst Massachusetts Eye &
Ear Boston MA USA;
Harvard Med Sch Schepens Eye Res Inst Massachusetts Eye &
Ear Boston MA USA;
MDM2; CRISPR/Cas9; SNP309; RPE; PVR;
机译:在原代人视网膜上皮细胞中引入MDM2 T309G突变可增强实验性增殖性玻璃体视网膜病变
机译:原发性人类视网膜上皮细胞中的MDM2 T309G突变增强了实验性增殖性玻璃体病虫病
机译:原发性人类视网膜上皮细胞中的MDM2 T309G突变增强了实验性增殖性玻璃体病虫病
机译:。人视网膜颜料上皮细胞对胶原基质的实验移植
机译:活性人眼中视网膜色素上皮细胞的自体荧光成像
机译:在原代人视网膜上皮细胞中引入MDM2 T309G突变可增强实验性增殖性玻璃体视网膜病变
机译:内源性或外源性视网膜色素上皮细胞:两种实验动物模型的增殖性玻璃体病变